NEWS
Print Your Certificate
The 2025 AD Scientific Index is here—explore updated university and researcher rankings!
New! Young University / Institution Rankings 2025
New! The 2025 Edition of the AD Scientific Index is now live!
New! Art & Humanities Rankings 2025
New! Social Sciences and Humanities Rankings 2025
"Exciting Update! The 2025 Edition of the AD Scientific Index is now live!
AD
Scientific Index 2025
Scientist Rankings
University Rankings
Subject Rankings
Country Rankings
login
Login
person_add
Register
insights
H-Index Rankings
insights
i10 Productivity Rankings
format_list_numbered
Citation Rankings
subject
University Subject Rankings
school
Young Universities
format_list_numbered
Top 100 Scientists
format_quote
Top 100 Institutions
format_quote
Compare & Choose
local_fire_department
Country Reports
Li Chung Tsao
Duke University - Durham / United States
Medical and Health Sciences / General Surgery
AD Scientific Index ID: 1365852
Registration, Add Profile,
Premium Membership
Print Your Certificate
Ranking &
Analysis
Job
Experiences (0)
Education
Information (0)
Published Books (0)
Book Chapters (0)
Articles (0)
Presentations (0)
Lessons (0)
Projects (0)
Congresses (0)
Editorship, Referee &
Scientific Board (0 )
Patents /
Designs (0)
Academic Grants
& Awards (0)
Artistic
Activities (0)
Certificate / Course
/ Trainings (0)
Association &
Society Memberships (0)
Contact, Office
& Social Media
person_outline
Li Chung Tsao's MOST POPULAR ARTICLES
1-)
Blocking type I interferon signaling enhances T cell recovery and reduces HIV-1 reservoirsL Cheng, J Ma, J Li, D Li, G Li, F Li, Q Zhang, H Yu, F Yasui, C Ye, ...The Journal of clinical investigation 127 (1), 269-279, 20171552017
2-)
NLRX1 sequesters STING to negatively regulate the interferon response, thereby facilitating the replication of HIV-1 and DNA virusesH Guo, R König, M Deng, M Riess, J Mo, L Zhang, A Petrucelli, SM Yoh, ...Cell host & microbe 19 (4), 515-528, 20161272016
3-)
Mechanisms of therapeutic antitumor monoclonal antibodiesLC Tsao, J Force, ZC HartmanCancer research 81 (18), 4641-4651, 2021972021
4-)
Vpr targets TET2 for degradation by CRL4VprBP E3 ligase to sustain IL-6 expression and enhance HIV-1 replicationL Lv, Q Wang, Y Xu, LC Tsao, T Nakagawa, H Guo, L Su, Y XiongMolecular cell 70 (5), 961-970. e5, 20181022018
5-)
CD47 blockade augmentation of trastuzumab antitumor efficacy dependent on antibody-dependent cellular phagocytosisLC Tsao, EJ Crosby, TN Trotter, P Agarwal, BJ Hwang, C Acharya, ...JCI insight 4 (24), 2019972019
ARTICLES
Add your articles
We use cookies to personalize our website and offer you a better experience. If you accept cookies, we can offer you special services.
Cookie Policy
Accept